National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

All

ATC	Name	B/G	Ingredients ↑	Dosage	Form	Price
M05BA04	OREK	G	Alendronate - 70mg	70mg	Tablet, coated	2,404,838 L.L
M05BA04	OSTEOMED	G	Alendronic acid (sodium alendronate) - 70mg	70mg	Tablet, scored	950,929 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.25mcg	0.25mcg	Capsule	1,138,235 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.5mcg	0.5mcg	Capsule	943,377 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.5mcg	0.5mcg	Capsule	942,034 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 1mcg	1mcg	Capsule	3,735,882 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 2mcg/ml	2mcg/ml	Injectable solution	2,218,684 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 2mcg/ml	2mcg/ml	Injectable solution	4,219,665 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 2mcg/ml	2mcg/ml	Drops solution	1,343,843 L.L
J01GB06	ORLOBIN	G	Amikacin (sulfate) - 500mg/2ml	500mg/2ml	Injectable solution	329,241 L.L
J01CA04	OSPAMOX	G	Amoxicillin (trihydrate) - 1g	1,000mg	Tablet, film coated	683,273 L.L
J01CA04	OSPAMOX	G	Amoxicillin (trihydrate) - 250mg/5ml	250mg/5ml	Powder for suspension	223,078 L.L
J01CA04	OSPAMOX	G	Amoxicillin (trihydrate) - 750mg	750mg	Tablet, film coated	499,372 L.L
L04AA32	OTEZLA	B	Apremilast - 30mg	30mg	Tablet, film coated	49,829,454 L.L
L04AA32	OTEZLA	B	Apremilast - 4x10mg- 4x20mg- 19x30mg		Tablet, film coated	34,751,325 L.L
N01BB58	ORABLOC	G	Articaine HCl - 4%, Epinephrine (tartrate) - 1/100.000		Injectable solution	2,308,721 L.L
C10AA05	ORBALIP	G	Atorvastatin (calcium) - 10mg	10mg	Tablet	966,287 L.L
C10AA05	ORBALIP	G	Atorvastatin (calcium) - 20mg	20mg	Tablet	1,091,712 L.L
C10AA05	ORBALIP	G	Atorvastatin (calcium) - 40mg	40mg	Tablet	1,405,275 L.L
C10AA05	ORVASTA	G	Atorvastatin - 10mg	10mg	Tablet, film coated	834,526 L.L
C10BA05	OTOREZA	G	Atorvastatin - 10mg, Ezetimibe - 10mg		Tablet, film coated	908,438 L.L
C10BA05	OTOREZA 10/10	G	Atorvastatin - 10mg, Ezetimibe - 10mg		Tablet, film coated	454,219 L.L
C10AA05	ORVASTA	G	Atorvastatin - 20mg	20mg	Tablet, film coated	920,532 L.L
C10BA05	OTOREZA 10MG/20MG	G	Atorvastatin - 20mg, Ezetimibe - 10mg		Tablet, film coated	858,715 L.L
C10AA05	ORVASTA	G	Atorvastatin - 40mg	40mg	Tablet, film coated	1,170,487 L.L
C10BA05	OTOREZA 10MG/40MG	G	Atorvastatin - 40mg, Ezetimibe - 10mg		Tablet, film coated	1,144,954 L.L
L04AA37	OLUMIANT	B	Baricitinib - 2mg	2mg	Tablet, film coated	68,053,864 L.L
L04AA37	OLUMIANT	B	Baricitinib - 4mg	4mg	Tablet, film coated	68,053,864 L.L
C09AA01	ORBACE	G	Captopril - 25mg	25mg	Tablet	522,179 L.L
C09AA01	ORBACE	G	Captopril - 50mg	50mg	Tablet	949,649 L.L

...